2025-12-28 - Analysis Report
Here's a comprehensive analysis of Lockheed Martin (LMT) based on the data provided:

**1. Performance vs. S&P 500 (VOO):**

*   **Company Overview:** Lockheed Martin Corp. is a global aerospace, defense, security, and advanced technologies company.
*   **LMT Cumulative Return:** 33.15%
*   **VOO Cumulative Return:** 103.21%
*   **Divergence:** -70.2 (Relative Divergence: 8.6)
*   **Analysis:** LMT has significantly underperformed the S&P 500. The negative divergence indicates substantial underperformance. The Relative Divergence of 8.6 suggests that the current divergence is near the lower end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2015-2017  | 44.0%  | 64.0%  | 15.0%  | 0.1   | 75.0   |
| 2016-2018  | 4.0%   | 73.6%  | -11.0% | -0.1  | 61.1   |
| 2017-2019  | 22.0%  | 79.0%  | 0.0%   | -0.8  | 90.9   |
| 2018-2020  | -26.0% | 79.0%  | -50.0% | -0.7  | 82.9   |
| 2019-2021  | 7.0%   | 79.0%  | -40.0% | 0.8   | 83.0   |
| 2020-2022  | -20.0% | 79.3%  | -19.0% | 0.6   | 113.6  |
| 2021-2023  | 15.0%  | 79.3%  | 14.0%  | 0.6   | 105.8  |
| 2022-2024  | 2.0%   | 79.3%  | -19.0% | 0.5   | 113.5  |
| 2023-2025  | 5.0%   | 79.8%  | -63.0% | 0.3   | 112.8  |

*   **CAGR:** Fluctuating over time, showing both strong growth periods (e.g., 2015-2017) and significant declines (e.g., 2018-2020).
*   **MDD:** High Maximum Drawdown (MDD) consistently around 70-80%, indicating significant potential for losses.
*   **Alpha:** Alpha is frequently negative, especially in more recent periods, suggesting LMT is underperforming relative to its risk.
*   **Beta:** Beta values are generally low, fluctuating around 0, indicating LMT's price is not strongly correlated with the market.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 483.03
*   **Previous Close:** 485.75
*   **Change:** -0.56
*   **5-day SMA:** 481.81
*   **20-day SMA:** 468.04
*   **60-day SMA:** 477.74
*   **Analysis:** The current price is below the previous close, indicating a slight recent decline. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA.

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 1.0 (High Investment Recommended)
*   **RSI:** 73.05 (Overbought)
*   **PPO:** 0.4825
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (5 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** -1.8 (Short-term decline)
*   **Expected Return (%):** -251.5
*   **Analysis:**
    *   The MRI suggests high investment potential, which is somewhat contradictory to other indicators.
    *   The RSI indicates an overbought condition, suggesting a potential pullback.
    *   The negative change in divergence over the past 20 days aligns with the recent price decline.
    *   The expected return is highly negative, suggesting poor long-term prospects compared to the S&P 500.

**4. Recent News & Significant Events:**

*   **Evaluating LMT Stock's Actual Performance (Motley Fool):** This suggests scrutiny of the company's financial health.
*   **Will Lockheed Martin (LMT) Shares Rebound? (Yahoo Finance):** This indicates investor uncertainty.
*   **Lockheed Martin Stock (LMT) Today: Pentagon Contract Boosts, F‑35 Scrutiny (ts2.tech):** Mixed news – positive contract news offset by ongoing scrutiny.
*   **Lockheed Martin Corporation $LMT Shares Acquired by Carnegie Investment Counsel (MarketBeat):** Positive signal as it shows institutional investors adding to their positions.
*   **KTOS vs. LMT: Which Defense Stock Is Better at Innovation? (Nasdaq):** Comparison suggests LMT might need to improve innovation.
*   **Lobbying Update: $60,000 of LOCKHEED MARTIN CORPORATION lobbying was just disclosed (Quiver Quantitative):** Lobbying efforts continue.

**4-2) Analyst Opinions:**

*   **Consensus:** Hold (2.62)
*   **Target Price:** $523.95 (avg)
*   **Analysis:** Analysts generally have a 'Hold' rating, suggesting they are neutral on the stock. The average target price is above the current price, implying some potential upside. However, given the other factors, this might not be fully reliable.

**5. Comprehensive Analysis:**

Overall, the analysis paints a mixed picture for Lockheed Martin (LMT).

*   **Negative Factors:**
    *   **Significant underperformance** compared to the S&P 500.
    *   Consistently **high Maximum Drawdown (MDD)** indicates potential for significant losses.
    *   Recent **negative changes** in relative divergence suggest short-term decline.
    *   **Highly negative expected return** suggests poor long-term prospects.
    *   **Overbought RSI** indicates a potential pullback.
*   **Potentially Positive Factors:**
    *   **High MRI** (although potentially misleading given other indicators).
    *   **Analyst target price** is slightly above the current price.
    *   The news shows a Carnegie Investment Counsel acquiring shares.
*   **Mixed Factors:**
    *   Recent news suggests both positive (Pentagon contract) and negative (F-35 scrutiny) influences.

**Conclusion:**

Based on this data, a cautious approach to investing in LMT is warranted. While the MRI suggests investment, other factors like underperformance, high risk, overbought conditions, and negative long-term projections raise concerns. The "Hold" consensus from analysts reflects this uncertainty. Investors should carefully weigh these factors and consider the negative expected return before investing.



**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.